Evidence map›Paper›PMID 39815828›Full record

ArticleBriefings in bioinformatics2024

A deep learning feature importance test framework for integrating informative high-dimensional biomarkers to improve disease outcome prediction.

Baiming Zou, James G Xenakis, Meisheng Xiao, Apoena Ribeiro, Kimon Divaris, Di Wu, Fei Zou

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Baiming ZouDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.ORCID 0000-0002-7879-9460
James G XenakisDepartment of Statistics, Harvard University, Cambridge, MA 02138, United States.ORCID 0000-0002-9307-9605
Meisheng XiaoDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.ORCID 0009-0000-2164-4794
Apoena RibeiroSchool of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.ORCID 0000-0001-7702-6178
Kimon DivarisSchool of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.ORCID 0000-0003-1290-7251
Di WuDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.ORCID 0000-0001-8331-2357
Fei ZouDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.ORCID 0000-0002-6637-3593

Funding

Robust Computational and Data Analytic Tools for In-depth Understanding Postoperative Pain Mechanism with Enhanced Pain Management and Clinical Decision MakingR01LM014407 · NLM · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Baiming Zou · 2024 to 2026
$1.4M
Enhanced Machine Learning Tools for Complex Data Evaluation and Integration in Advancing Health OutcomesR01HL173044 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Baiming Zou, Fei Zou · 2025 to 2026
$1.3M
Novel Deep Learning Tools for Clinical Decision Support in Postoperative Pain ManagementR56LM013784 · NLM · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZOU, BAIMING · 2022 to 2023
$832k
National Institutes of Health R56 1R56LM013784NHLBI NIH HHS R01 HL173044NLM NIH HHS R01 LM014407NLM NIH HHS R56 LM013784R01 R01LM014407
6 · The paper itself

Abstract

Many human diseases result from a complex interplay of behavioral, clinical, and molecular factors. Integrating low-dimensional behavioral and clinical features with high-dimensional molecular profiles can significantly improve disease outcome prediction and diagnosis. However, while some biomarkers are crucial, many lack informative value. To enhance prediction accuracy and understand disease mechanisms, it is essential to integrate relevant features and identify key biomarkers, separating meaningful data from noise and modeling complex associations. To address these challenges, we introduce the High-dimensional Feature Importance Test (HdFIT) framework for machine learning models. HdFIT includes a feature screening step for dimension reduction and leverages machine learning to model complex associations between biomarkers and disease outcomes. It robustly evaluates each feature's impact. Extensive Monte Carlo experiments and a real microbiome study demonstrate HdFIT's efficacy, especially when integrated with advanced models like deep neural networks. Our framework shows significant improvements in identifying crucial features and enhancing prediction accuracy, even in high-dimensional settings.

Indexed as

BiomarkersDeep LearningComputational BiologyHumansMonte Carlo MethodNeural Networks, ComputerBiomarkerscomplex associationdimension reductioninterpretable and scalable predictive modelingnon-parametric feature selectionstable deep neural network

Identifiers

PMID39815828
PMCPMC11735761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.